EDITORIAL SYNOPSIS Thirty-six patients with bilharzial hepatic fibrosis were investigated, and five other patients were studied before and after portacaval shunt operation. The liver parenchyma is well preserved in bilharzial hepatic fibrosis and this is reflected in the almost normal results of liver function tests. In 40% of the patients bromsulphalein was retained to an abnormal degree and retention was increased post-operatively in the patients studied before and after portacaval shunt operations. The increased retention of bromsulphalein was found to be the result of prehepatic factors, namely, diminished hepatic blood flow and increased systemic portal collateral circulation either singly or in combination.
In schistosomal hepatic fibrosis the various liver function tests give normal or only slightly abnormal results, particularly in tests depending on alterations in the serum proteins; these are not specific for liver diseases. Most other liver function tests yield normal results except the bromsulphalein retention test. This fact stimulated us to search for factors other than liver cell dysfunction which might modify the results.
PROCEDURE
Thirty-six patients with confirmed bilharzial hepatic fibrosis were studied. In addition to routine investigations, the icterus index, thymol turbidity, plasma proteins, and prothrombin activity were estimated.
Bromsulphalein was injected intravenously in a dose of 2 mg./kg. body weight (Kolmer, Spaulding, and Robinson, 1952) , and a sample of blood from the opposite arm was collected half an hour after the injection. Blood was then left to coagulate and serum was separated by centrifuging and 2 drops of a 10% solution of sodium hydroxide were added to the serum to bring out the colour. The amount of the dye retained in the serum was estimated by direct comparison with prepared standards. Retention of more than 10% of the dye was considered abnormal.
The portal pressure was measured by the intrasplenic technique in all the patients, the hepatic vein was catheterized in 26, the pressures were recorded in all, and the hepatic blood flow was estimated in 15 of them by the bromsulphalein clearance technique.
Liver biopsy specimens were obtained and examined in 28 patients.
Various tests were carried out to prove and assess the degree of systemic portal collateral circulation. These included radiological examination of the oesophagus for oesophageal varices. Portal collateral veins on the anterior abdominal wall were sought and demonstrated in some patients by infra-red photography. Splenoportography was carried out in 34 patients to study the intra-abdominal portal collateral veins, and haemorrhoids were detected by proctoscopy.
We also studied the results of bromsulphalein retention and other liver function tests in five patients with bilharzial hepatic fibrosis before and after portacaval shunt operations.
RESULTS
Results of bromsulphalein retention tests ranged from 2 to 36% of the injected dye. Normal values (up to 10%) were observed in 21 patients, while abnormal results ranging from 12 to 36 % were detected in the remaining 15 patients. It will be seen from Table I that of the liver function tests carried out in this study, the bromsulphalein retention test was the only one to show deviation from the normal in about two-fifths of the cases studied (41-6%). Two patients showed low values for prothrombin activity which was readily corrected by parenteral administration of vitamin K, in other words, hypoprothrombinaemia was not secondary to hepatocellular dysfunction.
Liver biopsy material was obtained in 28 patients, and examination showed the usual microscopic appearances of bilharzial liver fibrosis. The liver parenchyma was intact and showed no attempt at regeneration. A few layers only of liver cells were compressed and atrophied at the periphery of the 318 Fig. 1 show the relationship between these findings.
Hepatic blood flow was estimated in 15 patients. It ranged between 785 and 1,630 ml./min., and it was found that there was greater retention of bromsulphalein in the patients with a low hepatic blood flow. In 13 patients the hepatic blood flow was below (1,490 ml./min.) the normal mean (Nomeir, 1960; Bradley, Ingelfinger, Bradley, and Curry, 1945) . The normal range is 1,085 to 1,845 ml./min. (Bradley, 1949; Bradley et al., 1945 Table IV shows the results of bromsulphalein retention in the five patients studied before and after portacaval shunt operations. All of them showed a marked increase in the retention of the dye after the operation without any of the manifestations of parenchymal liver insufficiency. The other liver function tests were normal before operation and remained unaffected post-operatively. The retention of bromsulphalein before operation ranged from 0 to 11l3%, averaging 3l3%. Post-operatively it ranged from 13 6 to 34%, averaging 23l46%. group.bmj.com on June 23, 2017 -Published by http://gut.bmj.com/ Downloaded from dysfunction because less bromsulphalein will be presented to the liver, i.e., a prehepatic factor (Lichtman, 1953) , and by biliary obstruction even if there is normal blood flow and a normal transfer mechanism, i.e., a post-hepatic factor. The second factor was not found in our cases.
Liver function, as estimated by tests other than the bromsulphalein test, proved to be normal with the exception of a very mild abnormality in the thymol turbidity test in less than half of the cases. Hypoproteinaemia and the rare occurrence of hypoprothrombinaemia were proved not to be due to liver dysfunction since they were corrected by diet and vitamin K respectively. Furthermore the liver biopsy showed that the lesions were mainly mesenchymal and limited to the portal tracts with minimal damage to the parenchyma; some of the liver cells at the periphery of the lobules may be affected by compression. There was no relation between the results of thymol turbidity tests, liver biopsy, measurement of portal pressure, and the bromsulphalein extraction (Table I) . These results provide further evidence that the bromsulphalein test cannot be considered as an accurate measure of hepatocellular function.
Study of the prehepatic factors influencing bromsulphalein retention, namely, the hepatic blood flow and the degree of systemic collateral portal veins, showed that they have a definite relation to the results of bromsulphalein retention. Thus all the patients who retained more than 10% bromsulphalein showed either diminished hepatic blood flow, significant systemic portal collateral veins, or both. The only exceptions were the three patients who had no significant collateral veins and yet retained more than 10% of the injected bromsulphalein. It is unfortunate that in none of these three patients was hepatic blood flow estimated, but judging by the size of the liver, which proved in our previous studies (Nomeir, 1960) a useful source of information about hepatic blood flow, we feel that had they had the blood flow estimated, it would have been below 1,000 ml. per minute.
The normal liver takes about half an hour to get rid of 90% of the standard dose of bromsulphalein used in the test. This time is needed to allow for repeated passages of blood through the liver at a rate of about 1,500 ml./min. In the presence of diminished hepatic blood flow, although 30 minutes are sufficient for the whole blood to recirculate several times through the liver, the total amount that passes during the period of the test is definitely less than the normal. Therefore with diminished hepatic blood flow, liver cells with normal excretory power may not be able to excrete 90% of the dye. It is thus not surprising that we found that there is more retention of bromsulphalein in the patients with a low hepatic blood flow. Lichtman (1953) is of the same opinion.
Systemic portal collateral veins help to diminish the hepatic blood flow (Nomeir, 1960) . Furthermore they prolong the time needed for efficient recirculation even if the hepatic blood flow is not grossly impaired. This explains our findings that retention of the dye was maximum in patients with the most marked portal collateral veins.
The increased retention of bromsulphalein after a portacaval shunt operation is a good example of the influence of the prehepatic factors. Liver function was normal before operation and the retention of bromsulphalein was very low. After the operation, although liver function remained intact, retention of bromsulphalein was markedly increased. The operation creates an augmented systemic portal anastomosis which is associated with a decrease in hepatic blood flow. 
